Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric Project for the Prospective Identification and Validation of Molecular Alterations That Define the "BRCANess" Profile in Ovarian Epithelial Cancer and Its Application as a Response Predictor to Platinum and Antitarget Therapies in the Clinical Practice. The Finding BRCANess Project

NCT02524808 is registered in ClinicalTrials.gov with Fundación de investigación HM as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02524808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric Project for the Prospective Identification and Validation of Molecular Alterations That Define the "BRCANess" Profile in Ovarian Epithelial Cancer and Its Application as a Response Predictor to Platinum and Antitarget Therapies in the Clinical Practice. The Finding BRCANess Project
Lead sponsor
Fundación de investigación HM
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2015
Completion date
July 31, 2016
Enrollment
230 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.